Josep Gómez

Associate Professor

Universitat Rovira i Virgili

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Josep Gómez is an Associate Professor at Universitat Rovira i Virgili in Spain. His research focuses on critical care medicine, particularly machine learning applications in intensive care settings, predictive modeling for patient outcomes, and the impact of various treatments in critically ill patients. Recent articles include studies on ICU mortality risk factors, the effectiveness of empirical antibiotic use during pandemic viral infections, and the impact of treatment protocols on patient outcomes.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Luciano Santana Cabrera

Head of Section/Jefatura de Sección

SPAIN

View details

MARIA BODÍ

Juntendo University Hospital

SPAIN

View details

Alejandro Rodriguez Oviedo

Head of section ICU - Cont.

SPAIN

View details

David Riaño

Associate Professor

Universitat Rovira i Virgili

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Josep Gómez

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Machine Learning-Based Identification of Risk Factors for ICU Mortality in 8902 Critically Ill Patients with Pandemic Viral Infection

Combining Predictive Models of Mortality and Time-to-Discharge for Improved Outcome Assessment in Intensive Care Units

Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective Study

Assessing the impact of real-time random safety audits through full propensity score matching on reliable data from the clinical information system

Applicability of an unsupervised cluster model developed on first wave COVID-19 patients in second/third wave critically ill patients

Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: a targeted maximum likelihood estimation and survival analysis

NEGATIVE PREDICTIVE VALUE OF PROCALCITONIN TO RULE OUT BACTERIAL RESPIRATORY CO-INFECTION IN CRITICAL COVID-19 PATIENTS.

Analysis of adherence to an early mobilization protocol in an intensive care unit: Data collected prospectively over a period of three years by the clinical information system

Secondary use of data extracted from a clinical information system to assess the adherence of tidal volume and its impact on outcomes

Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study

Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study

Understanding critically ill sepsis patients with normal serum lactate levels: results from U.S. and European ICU cohorts.

Varying association of laboratory values with reference ranges and outcomes in critically ill patients: an analysis of data from five databases in four countries across Asia, Europe and North America.

A Differential Therapeutic consideration for use of Corticosteroids according to Established COVID-19 Clinical Phenotypes in Critically ill Patients

Corticosteroids and RCTs against the supposed undervaluation of real data evidence.

Methods and measures to quantify ICU patient heterogeneity.

Collaborators (4)

Luciano Santana Cabrera

MARIA BODÍ

Alejandro Rodriguez Oviedo

David Riaño

Make your next move.